For patients taking blood-thinning medications, consistent monitoring is essential to ensure treatment remains both safe and effective.
At Springlife Medical, we provide reliable PT/INR testing in West Islip, NY, helping patients maintain proper blood clotting levels while reducing the risk of complications. Serving West Islip and surrounding Long Island communities, our in-office testing allows for timely adjustments and coordinated care.
Monitoring is not just about numbers, it’s about keeping you safely within the right therapeutic range.
PT/INR testing measures how quickly your blood clots and evaluates how well anticoagulant medications are working.
These values help ensure your blood is not clotting too quickly (which increases risk of clots) or too slowly (which increases risk of bleeding).
Patients on anticoagulants such as warfarin require regular PT/INR testing to:
Even small changes in INR levels can significantly impact safety, making routine monitoring essential.
We provide PT/INR monitoring for patients with:
We also monitor patients when medications, diet, or health status changes may affect clotting levels.
Having PT/INR testing available within your primary care office offers important advantages:
This improves both safety and convenience, especially for patients requiring ongoing monitoring.
PT/INR testing at Springlife Medical is overseen by Dr. Sumeet K. Anand, a board-certified internist with over 20 years of experience managing complex medical conditions and anticoagulation therapy.
Dr. Anand evaluates your results in the context of your full medical profile, ensuring treatment decisions are precise, safe, and tailored to your needs.
Springlife Medical proudly provides PT/INR monitoring for patients in:
Testing is available as part of routine care and chronic condition management visits.
If you are taking blood thinners, regular monitoring is essential to maintaining your health and safety.
Call Springlife Medical today to schedule PT/INR testing in West Islip, or request an appointment online.